The Serotonin Syndrome

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025

The serotonin syndrome

Sternbach, H. A. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.6.705 · Cited by 1,349

The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity

Dunkley, E. J. C., Isbister, G. K., Sibbritt, D. W., Dawson, A. H., & Whyte, I. M. (2003) · QJM · doi:10.1093/qjmed/hcg109 · Cited by 1,032

Neuroleptic malignant syndrome

Levenson, J. L. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.10.1137 · Cited by 984

2002 annual report of the American association of poison control centers toxic exposure surveillance system

Watson, W. A., Litovitz, T. L., Rodgers, G. C., Klein‐Schwartz, W., Youniss, J., Rose, S. R., Borys, D. J., & May, M. E. (2003) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(03)00088-3 · Cited by 481

Interactions Between Herbal Medicines and Prescribed Drugs

Izzo, A., & Ernst, E. (2012) · Drugs · doi:10.2165/00003495-200161150-00002 · Cited by 464

Relative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose

Isbister, G. K., Bowe, S. J., Dawson, A. H., & Whyte, I. M. (2004) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120037428 · Cited by 432

The Libby Zion Case

Asch, D. A., & Parker, R. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803243181209 · Cited by 396

Effects of Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy on Serotonergic Symptoms in Newborns and Cord Blood Monoamine and Prolactin Concentrations

Laine, K., Heikkinen, T., Ekblad, U., & Kero, P. O. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.720 · Cited by 329

Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity

Parrott, A. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00711-0 · Cited by 325

Drug Interactions with Triptans

Rolan, P. E. (2012) · CNS Drugs · doi:10.1007/s40263-012-0002-5 · Cited by 27

Topiramate-Induced Palinopsia

Yun, S., Lavin, P., Schatz, M. P., & Lesser, R. L. (2015) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000216 · Cited by 27

Initial Diagnosis and Management of Coma

Traub, S. J., & Wijdicks, E. F. M. (2016) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2016.06.017 · Cited by 27

Manic Switch in a Patient With Treatment-Resistant Bipolar Depression Treated With Modafinil

Wolf, J., Fiedler, U., Anghelescu, I. G., & Schwertfeger, N. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1122a · Cited by 27

Serotonin Syndrome Associated with the Use of Escitalopram

Huska, M. T., Catalano, G., & Catalano, M. C. (2007) · CNS Spectrums · doi:10.1017/s1092852900021027 · Cited by 27

Serotonin Syndrome Risks When Combining SSRI/SNRI Drugs and Triptans: is the FDA's Alert Warranted?

Wenzel, R. G., Tepper, S. J., Korab, W. E., & Freitag, F. G. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l260 · Cited by 26

A case of fatal intoxication due to the new designer drug 25B-NBOMe

Yoshida, K., Saka, K., Shintani‐Ishida, K., Maeda, H., Nakajima, M., Hara, S., Ueno, M., Sasaki, K., Iwase, H., & Sakamoto, T. (2015) · Forensic Toxicology · doi:10.1007/s11419-015-0276-7 · Cited by 26

Kreislaufstillstand unter besonderen Umständen: Elektrolytstörungen, Vergiftungen, Ertrinken, Unterkühlung, Hitzekrankheit, Asthma, Anaphylaxie, Herzchirurgie, Trauma, Schwangerschaft, Stromunfall

Soar, J., Perkins, G. D., Abbas, G., Alfonzo, A. V. M., Barelli, A., Bierens, J., Brugger, H., Deakin, C. D., Dunning, J., Georgiou, M., et al. (2010) · Notfall + Rettungsmedizin · doi:10.1007/s10049-010-1374-z · Cited by 24

An Open-Label Pilot Study of Combined Augmentation With Creatine Monohydrate and 5-Hydroxytryptophan for Selective Serotonin Reuptake Inhibitor– or Serotonin-Norepinephrine Reuptake Inhibitor–Resistant Depression in Adult Women

Kious, B. M., Sabic, H., Sung, Y., Kondo, D. G., & Renshaw, P. F. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000754 · Cited by 26

RYR1-Related Rhabdomyolysis: A Spectrum of Hypermetabolic States Due to Ryanodine Receptor Dysfunction

Kruijt, N., van den Bersselaar, L. R., Snoeck, M. M. J., Kramers, K., Riazi, S., Bongers, C. C. W. G., Treves, S., Jungbluth, H., & Voermans, N. C. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210804095300 · Cited by 26

5‐(2‐Aminopropyl)indole (5‐IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO)

Herraiz, T., & Brandt, S. D. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1530 · Cited by 26

Small doses of methylene blue, previously considered safe, can precipitate serotonin toxicity

Schwiebert, C., Irving, C., & Gillman, P. K. (2009) · Anaesthesia · doi:10.1111/j.1365-2044.2009.06029.x · Cited by 26

Serotonin Syndrome Caused by Fentanyl and Methadone in a Burn Injury

Hillman, A. D., Witenko, C. J., Sultan, S. M., & Gala, G. J. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1528 · Cited by 26

Characterization of serotonin-toxicity syndrome (toxidrome) elicited by 5-hydroxy-l-tryptophan in clorgyline-pretreated rats

Ma, Z., Zhang, G., Jenney, C. B., Krishnamoorthy, S., & Tao, R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.04.004 · Cited by 26

Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors

Jiang, X.-L., Shen, H.-W., & Yu, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.013 · Cited by 26

Rhabdomyolysis After LSD Ingestion

Berrens, Z. J., Lammers, J., & White, C. (2010) · Psychosomatics · doi:10.1016/s0033-3182(10)70711-8 · Cited by 26

Parkinsonism–hyperpyrexia syndrome: The role of electroconvulsive therapy

Meagher, L. J., McKay, D., Herkes, G., & Needham, M. (2006) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2005.09.017 · Cited by 26

Potential mechanisms and markers of critical illness-associated cognitive dysfunction

Milbrandt, E. B., & Angus, D. C. (2005) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000170508.63067.04 · Cited by 26

Serotonin Syndrome versus Cannabis Toxicity in the Emergency Department

Baltz, J., & Le, L. (2020) · Clinical Practice and Cases in Emergency Medicine · doi:10.5811/cpcem.2020.1.45410 · Cited by 25

Current pharmacotherapy for obesity: extrapolation of clinical trials data to practice

Gadde, K. M. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.890590 · Cited by 26

Probable Tapentadol-Associated Serotonin Syndrome after Overdose

Walczyk, H., Liu, C. H., Alafris, A., & Cohen, H. (2016) · Hospital Pharmacy · doi:10.1310/hpj5104-320 · Cited by 25

Metoclopramide-induced Serotonin Syndrome

Harada, T., Hirosawa, T., Morinaga, K., & Shimizu, T. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.7727 · Cited by 25

Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review

Wang, M., Wang, W., Gao, Z., Yin, X., Chen, T., Jiang, Z., & Wang, Z. (2021) · Clinical Autonomic Research · doi:10.1007/s10286-021-00801-w · Cited by 25

Drug-Induced Hyperthermia Review

Horseman, M. A., Panahi, L., Udeani, G., Tenpas, A., Verduzco, R., Patel, P. H., Bazan, D. Z., Mora, A., Samuel, N. G., Mingle, A.-C., et al. (2022) · Cureus · doi:10.7759/cureus.27278 · Cited by 26

Assessment of 5-hydroxytryptamine efflux in rat brain during a mild, moderate and severe serotonin-toxicity syndrome

Zhang, G., Krishnamoorthy, S., Ma, Z., Vukovich, N. P., Huang, X., & Tao, R. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.05.008 · Cited by 25

Consistency of psychotropic drug–drug interactions listed in drug monographs

Liu, X., Hatton, R. C., Zhu, Y., Hincapie‐Castillo, J. M., Bussing, R., Barnicoat, M., & Winterstein, A. G. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2017.07.008 · Cited by 26

Administration of Ondansetron Is Associated With Lethal Outcome

Gener, B., Burns, J. M., Griffin, S., & Boyer, E. W. (2010) · PEDIATRICS · doi:10.1542/peds.2009-2795 · Cited by 25

A Case of Serotonin Syndrome and Mutism associated with Methadone

Bush, E., Miller, C., & Friedman, I. H. (2006) · Journal of Palliative Medicine · doi:10.1089/jpm.2006.9.1257 · Cited by 25

Are Neuroleptic Malignant Syndrome and Serotonin Syndrome the Same Syndrome?

Steele, D., Keltner, N. L., & McGuinness, T. M. (2010) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.2010.00292.x · Cited by 24

“Noids” in a nutshell: everything you (don’t) want to know about synthetic cannabimimetics

Papanti, D., Orsolini, L., Francesconi, G., & Schifano, F. (2014) · Advances in Dual Diagnosis · doi:10.1108/add-02-2014-0006 · Cited by 24

Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants

Beyer, C., Cappetta, K., Johnson, J. A., & Bloch, M. H. (2017) · Depression and Anxiety · doi:10.1002/da.22680 · Cited by 24

Serotonin syndrome

Maitland, S., & Baker, M. R. (2022) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2021.000032 · Cited by 24

Serotonin toxicity: a short review of the literature and two case reports involving Citalopram

Talarico, G., Tosto, G., Pietracupa, S., Piacentini, E., Canevelli, M., Lenzi, G. L., & Bruno, G. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0546-z · Cited by 24

Drug-induced hyperthermia in critical care

Walter, E. J., & Carraretto, M. (2015) · Journal of the Intensive Care Society · doi:10.1177/1751143715583502 · Cited by 24

Treatment-Resistant Depression in Adolescents: Recognition and Management

Brent, D. A., & Birmaher, B. B. (2006) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2006.05.001 · Cited by 23

Serotonin syndrome following drug–drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient

Lorenzini, K. I., Calmy, A., Ambrosioni, J., Assouline, B., Daali, Y., Fathi, M., Rebsamen, M. C., Desmeules, J. A., & Samer, C. F. (2012) · AIDS · doi:10.1097/qad.0b013e32835a11ba · Cited by 24

Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis

Galling, B., Ferrer, A. C., Daou, M. A. Z., Sangroula, D., Hagi, K., & Correll, C. U. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1085970 · Cited by 24

Meperidine-induced serotonin syndrome in a susceptible patient

Guo, S.-L., Wu, T.-J., Liu, C., Ng, C.-C., Chien, C., & Sun, H.-L. (2009) · British Journal of Anaesthesia · doi:10.1093/bja/aep167 · Cited by 24

Increasing motor neuron excitability to treat weakness in sepsis

Nardelli, P., Powers, R. K., Cope, T. C., & Rich, M. M. (2017) · Annals of Neurology · doi:10.1002/ana.25105 · Cited by 24

Influence of aging on opioid dosing for perioperative pain management: a focus on pharmacokinetics

Mercadante, S. (2024) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-024-00182-2 · Cited by 23

Serotonin Syndrome Following Methylene Blue Administration During Cardiothoracic Surgery

Smith, C. J., Wang, D. T., Sgambelluri, A., Kramer, R. S., & Gagnon, D. J. (2015) · Journal of Pharmacy Practice · doi:10.1177/0897190014568389 · Cited by 23

Serotonin Syndrome

Cooper, B. E., & Sejnowski, C. A. (2013) · AACN Advanced Critical Care · doi:10.1097/nci.0b013e31827eecc6 · Cited by 25

Effects of gut microbiota and probiotics on Alzheimer’s disease

Guo, L., Xu, J., Du, Y., Wu, W., Nie, W., Zhang, D., Luo, Y., Lu, H., Lei, M., Xiao, S., et al. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2020-0203 · Cited by 25

Real-time monitoring of serotonin with highly selective aptamer-functionalized conducting polymer nanohybrids

Lim, S. G., Seo, S. E., Park, S. J., Kim, J., Kim, Y., Kim, K. H., An, J. E., & Kwon, O. S. (2022) · Nano Convergence · doi:10.1186/s40580-022-00325-7 · Cited by 23

Burden of disease is often aggravated by opioid treatment of chronic pain patients: Etiology and prevention

Breivik, H., & Stubhaug, A. (2014) · Pain · doi:10.1016/j.pain.2014.09.011 · Cited by 23

Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats

Tao, R., Shokry, I. M., Callanan, J. J., Adams, H. D., & Ma, Z. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3759-z · Cited by 23

Linezolid interaction with serotonin reuptake inhibitors: report of two cases and incidence assessment

Go, A. C., Golightly, L. K., Barber, G. R., & Barron, M. A. (2010) · Drug metabolism and drug interactions · doi:10.1515/dmdi.2010.001 · Cited by 23

Serotonin syndrome following Methylene Blue infusion: a rare complication of antidepressant therapy

Barras, A. C. H., Walder, B., & Seeck, M. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.172221 · Cited by 23

Suspected serotonin syndrome in a patient being treated with methylene blue for ifosfamide encephalopathy

McDonnell, A., Rybak, I., Wadleigh, M., & Fisher, D. (2012) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155211433231 · Cited by 23

Overlapping of Serotonin Syndrome with Neuroleptic Malignant Syndrome due to Linezolid‐Fluoxetine and Olanzapine‐Metoclopramide Interactions: A Case Report of Two Serious Adverse Drug Effects Caused by Medication Reconciliation Failure on Hospital Admission

Mazhar, F., Akram, S. K., Haider, N., & Ahmed, R. (2016) · Case Reports in Medicine · doi:10.1155/2016/7128909 · Cited by 23

Catatonia secondary to anti-N-methyl-D-aspartate receptor (NMDAr) encephalitis: a review

Macedo, I. M., & Marques, J. G. (2019) · CNS Spectrums · doi:10.1017/s1092852919001573 · Cited by 23

Psychopharmacology

Thronson, L. R., & Pagalilauan, G. L. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.06.001 · Cited by 24

Anesthetic Considerations for Patients on Antidepressant Therapy – Part II

Saraghi, M., Golden, L. R., & Hersh, E. V. (2018) · Anesthesia Progress · doi:10.2344/anpr-65-01-10 · Cited by 23

Is Tapentadol an Advance on Tramadol?

Guay, D. R. P. (2009) · The Consultant Pharmacist · doi:10.4140/tcp.n.2009.833 · Cited by 23

Linezolid and Serotonergic Drug Interactions

Taylor, J. J., Estes, L. L., & Wilson, J. W. (2006) · Clinical Infectious Diseases · doi:10.1086/508663 · Cited by 23

Serotonin Syndrome After Methylene Blue Administration During Cardiac Surgery: A Case Report and Review

Wolvetang, T., Janse, R., & ter Horst, M. (2015) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2015.11.019 · Cited by 22

Serotonin Syndrome Following Methylene Blue Administration for Vasoplegic Syndrome

Hencken, L. N., To, L., Ly, N., & Morgan, J. A. (2016) · Journal of Cardiac Surgery · doi:10.1111/jocs.12705 · Cited by 22

The prevalence of serotonin syndrome in an intensive care unit: A prospective observational study

Prakash, S., Rathore, C., & Rana, K. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.12.014 · Cited by 24

Diagnosis of Acute Poisoning using explainable artificial intelligence

Chary, M. A., Boyer, E. W., & Burns, M. M. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104469 · Cited by 23

Drugs of Abuse

Brown, H. S., & Pollard, K. A. (2021) · Critical Care Clinics · doi:10.1016/j.ccc.2021.03.002 · Cited by 22

Drugs and pharmaceuticals: management of intoxication and antidotes

Smith, S. W. (2010) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-7643-8338-1_12 · Cited by 24

Augmenting Selective Serotonin Reuptake Inhibitors With Clomipramine in Obsessive-Compulsive Disorder: Benefits and Risks

Andrade, C. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13f08883 · Cited by 22

Nephrotoxicity of recreational party drugs

Berney‐Meyer, L., Putt, T. L., Schollum, J. B. W., & WALKER, R. (2011) · Nephrology · doi:10.1111/j.1440-1797.2011.01537.x · Cited by 22

Serotonin Syndrome in the Setting of Lamotrigine, Aripiprazole, and Cocaine Use

Kotwal, A., & Cutrona, S. L. (2015) · Case Reports in Medicine · doi:10.1155/2015/769531 · Cited by 22

Serotonin catabolism in the central and enteric nervous systems of rats upon induction of serotonin syndrome

Squires, L. N., Talbot, K. N., Rubakhin, S. S., & Sweedler, J. V. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04739.x · Cited by 23

Rethinking the role of opioids in the outpatient management of chronic nonmalignant pain

Provenzano, D. A., & Viscusi, E. R. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.921610 · Cited by 22

Venlafaxine as the ‘baby ecstasy’? Literature overview and analysis of web‐based misusers′ experiences

Francesconi, G., Orsolini, L., Papanti, D., Corkery, J., & Schifano, F. (2015) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2476 · Cited by 22

Pharmacogenomics in Psychiatry: Implications for Practice

Moore, T. R., Hill, A. M., & Panguluri, S. K. (2014) · Recent Patents on Biotechnology · doi:10.2174/1872208309666140904113615 · Cited by 22

Unsuspected serotonin toxicity in the ICU

van Ewijk, C. E., Jacobs, G. E., & Girbes, A. R. J. (2016) · Annals of Intensive Care · doi:10.1186/s13613-016-0186-9 · Cited by 22

In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks

Wagmann, L., Brandt, S. D., Kavanagh, P. V., Maurer, H. H., & Meyer, M. R. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.03.007 · Cited by 22

The Poisoned Pediatric Patient

Toce, M. S., & Burns, M. M. (2017) · Pediatrics in Review · doi:10.1542/pir.2016-0130 · Cited by 22

The scoop on serotonin syndrome

Foong-Reichert, A.-L., Patel, T., Kellar, J., & Grindrod, K. (2018) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163518779096 · Cited by 22

Potential Roles of microRNAs in the Regulation of Monoamine Oxidase A in the Brain

Higuchi, Y., Soga, T., & Parhar, I. S. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00339 · Cited by 22

Leg movements during sleep in children treated with serotonergic antidepressants

Ferri, R., Mogavero, M. P., Bruni, O., Picchietti, D. L., Kapoor, V., & DelRosso, L. M. (2021) · SLEEP · doi:10.1093/sleep/zsab236 · Cited by 22

Randomized Open-Label Drug-Drug Interaction Trial of Dextromethorphan/Quinidine and Paroxetine in Healthy Volunteers

Schoedel, K. A., Pope, L. E., & Sellers, E. M. (2012) · Clinical Drug Investigation · doi:10.2165/11599870-000000000-00000 · Cited by 22

Pharmacologic Safety Concerns in Parkinson's Disease: Facts and Insights

Chen, J. J. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2011.620193 · Cited by 22

Identifying and treating patients with synthetic psychoactive drug intoxication

Brown, G. R., McLaughlin, K., & Vaughn, K. (2018) · JAAPA · doi:10.1097/01.jaa.0000541487.41149.71 · Cited by 22

Triptan migraine treatments and antidepressants: risk of serotonin syndrome

Wooltorton, E. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.061217 · Cited by 22

Antidepressant Drugs: Mechanisms of Action and Side Effects

Chang, J. P., Zamparelli, A., Nettis, M. A., & Pariante, C. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819641-0.00105-5 · Cited by 22

The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue

Marusich, J. A., Antonazzo, K. R., Blough, B. E., Brandt, S. D., Kavanagh, P. V., Partilla, J. S., & Baumann, M. H. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.004 · Cited by 21

Acute heart failure associated with venlafaxine poisoning

Fangio, P., Jonghe, B. D., Appéré-De-Vecchi, C., Lachérade, J.-C., Jp, T., Outin, H., & Dagorn, J. (2007) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2006.08.007 · Cited by 21

New Drugs of Abuse and Withdrawal Syndromes

Andrabi, S., Greene, S. C., Moukaddam, N. J., & Li, B. (2015) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2015.07.006 · Cited by 21

Refining the clinical features of serotonin syndrome: A prospective observational study of 45 patients

Prakash, S., Rathore, C., Rana, K., Dave, A., Joshi, H., & Patel, J. (2018) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_344_18 · Cited by 21

Cerebral MAO Activity Is Not Altered by a Novel Herbal Antidepressant Treatment

Doron, R., Versano, Z., Burstein, O., Franko, M., Shamir, A., Toledano, R., Handelsman, A., & Rehavi, M. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01366-0 · Cited by 21

Mephedrone and chemsex: when it stops being a party and becomes a fatal problem

Troya, J., de Gándara, A. M., Ryan, P., Cuevas, G., & Pardo, V. (2019) · International Journal of STD & AIDS · doi:10.1177/0956462419857004 · Cited by 21

Use of Cyproheptadine for the Treatment of Serotonin Syndrome

Frye, J., Poggemiller, A. M., McGonagill, P. W., Pape, K., Galet, C., & Liu, Y. M. (2019) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001159 · Cited by 21

SSRIs: Applications in inflammatory lung disease and implications for COVID‐19

Meikle, C. K., Creeden, J. F., McCullumsmith, C. B., & Worth, R. G. (2021) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12194 · Cited by 20

Coma Induced by Intoxication

Paepe, P. D., Calle, P. A., & Buylaert, W. A. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01709-5 · Cited by 21

The Use of Selective Serotonin Reuptake Inhibitors in Elderly Patients

Chemali, Z. N., Chahine, L. M., & Fricchione, G. L. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220903129798 · Cited by 21

Status epilepticus following intentional overdose of fluvoxamine: A case report with serum fluvoxamine concentration

Wood, D. M., Rajalingam, Y., Greene, S. L., Morgan, P. E., Gerrie, D., Jones, A. L., & Dargan, P. I. (2007) · Clinical Toxicology · doi:10.1080/15563650701664574 · Cited by 21

The serotonin syndrome—the need for physician’s awareness

Arora, B., & Kannikeswaran, N. (2010) · International Journal of Emergency Medicine · doi:10.1007/s12245-010-0195-7 · Cited by 21

Psychiatric Considerations in Patients with Decreased Levels of Consciousness

Young, J. L., & Rund, D. A. (2010) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2010.03.010 · Cited by 21

Hallucinogen persisting perception disorder in neuronal networks with adaptation

Kilpatrick, Z. P., & Ermentrout, B. (2011) · Journal of Computational Neuroscience · doi:10.1007/s10827-011-0335-y · Cited by 21

Serotonin syndrome secondary to tramadol and citalopram

Peacock, L. E., & Wright, F. (2011) · Age and Ageing · doi:10.1093/ageing/afr017 · Cited by 21

Tramadol Overdose: A Case Report

Pothiawala, S. E., & Ponampalam, R. (2011) · Proceedings of Singapore Healthcare · doi:10.1177/201010581102000311 · Cited by 21

Serotonin syndrome caused by drug to drug interaction between escitalopram and dextromethorphan

Dy, P., Arcega, V. A., Ghali, W., & Wolfe, W. (2017) · BMJ Case Reports · doi:10.1136/bcr-2017-221486 · Cited by 21

Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood-Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases.

Gealageas, R., Devineau, A., So, P. P. L., Kim, C., Surendradoss, J., Buchwalder, C., Heller, M., Goebeler, V., Dullaghan, E., Grierson, D., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01588 · Cited by 20

Serotonin syndrome in the perioperative period

Bartakke, A., Corredor, C., & van Rensburg, A. (2019) · BJA Education · doi:10.1016/j.bjae.2019.10.003 · Cited by 21

Serotonin Syndrome as a Complication of Fentanyl Sedation During Esophagogastroduodenoscopy

Alkhatib, A. A., Peterson, K. A., & Tuteja, A. K. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0711-x · Cited by 21

Serotonin syndrome manifesting as patient movement during total intravenous anesthesia with propofol and remifentanil

Davis, J. J., Buck, N. S., Swenson, J. D., Johnson, K. B., & Greis, P. E. (2013) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2012.05.002 · Cited by 21

Serotonin Syndrome

Ternaux, J.-P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374105-9.00421-4

Síndrome Serotoninérgico

Azofeifa, M. M., Chaves, J. C. V., Jiménez, S. V., & Díaz, F. A. (2019) · Americanae (AECID Library)

Serotonin syndrome in the perioperative period

Bartakke, A., Corredor, C., & van Rensburg, A. (2019) · BJA Education · doi:10.1016/j.bjae.2019.10.003 · Cited by 21

Serotonin Syndrome Following Single Ingestion of High Dose Methamphetamine

Rahmani, S. H. (2011) · Journal of Clinical Toxicology · doi:10.4172/2161-0495.1000111 · Cited by 5

Practice pointer: serotonin syndrome

Buckley, N. A., Dawson, A. H., & Isbister, G. K. (2014) · NOVA (University of Newcastle Australia)